Liminatus Pharma, Inc.

LIMN·NASDAQ·$0.16Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2510/06/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report08/18/26 8-KCurrent report08/04/26 8-KCurrent report07/30/26 8-KCurrent report07/24/26

Prospectuses and Registrations

S-1Registration statement (IPO)06/24/26 424B3Prospectus06/03/26 424B4Prospectus02/18/26 S-1Registration statement (IPO)02/11/26 424B3Prospectus08/13/25

Proxies

DEF 14ADefinitive proxy07/13/26 PRE 14APreliminary proxy06/30/26

Ownership

SC 13GBeneficial ownership07/22/26 Form 4Insider transaction07/14/26 SC 13D/ABeneficial ownership (amended)07/14/26 Form 3Initial insider ownership07/06/26 Form 4Insider transaction07/06/26

Other

DD06/18/26 EFFECTRequest for effectiveness02/13/26 CORRESPCorrespondence with the SEC02/11/26 CORRESPCorrespondence with the SEC02/11/26 UPLOADLetter from the SEC01/06/26